[Current possibilities of reducing the incidence of post-perfusion pulmonary syndrome].
作者信息
Bergui G C
出版信息
Minerva Cardioangiol. 1977 Apr;25(4):347-64.
PMID:329158
Abstract
摘要
相似文献
1
[Current possibilities of reducing the incidence of post-perfusion pulmonary syndrome].
Minerva Cardioangiol. 1977 Apr;25(4):347-64.
2
Pulmonary changes common to isolated lung perfusion, venovenous bypass, and total cardiopulmonary bypass.
Surg Gynecol Obstet. 1967 Nov;125(5):1047-57.
3
Postoperative pulmonary dysfunction in adults after cardiac surgery with cardiopulmonary bypass: clinical significance and implications for practice.
Am J Crit Care. 2004 Sep;13(5):384-93.
4
Pulmonary complications of cardiopulmonary bypass.
Best Pract Res Clin Anaesthesiol. 2015 Jun;29(2):163-75. doi: 10.1016/j.bpa.2015.04.002. Epub 2015 Apr 23.
5
Treatment or prevention of pulmonary cellular damage with pharmacologic doses of corticosteroid.
Surg Gynecol Obstet. 1972 Apr;134(4):675-81.
6
[Postperfusion pulmonary syndrome. Its determination, pathomorphology, etiological factors and pathogenetic mechanisms].
Khirurgiia (Sofiia). 1978;31(1):57-65.
7
[On respiratory insufficiency following heart surgery with the use of extracorporeal circulation; the so-called "post-perfusion lung syndrome"].
Zentralbl Chir. 1967 Apr 22;92(16):561-7.
8
[Influence of respiratory alkalosis during extracorporeal circulation, in incidence of metabolic acidosis].
Arq Bras Cardiol. 1970 Feb;23(1):17-34.
9
A case of fatal fat embolism syndrome following cardiopulmonary bypass.
J Thorac Cardiovasc Surg. 1976 Aug;72(2):202-5.
10
Ultrastructure of human myocardium after total cardiopulmonary bypass during open-heart surgery.
Recent Adv Stud Cardiac Struct Metab. 1975;6:399-404.
Zotero 插件